Abstract:Introduction Voxel based morphometry (VBM) is a neuroimaging analysis technique that allows investigation of focal differences in brain anatomy, using the statistical approach of so-called statistical parametric mapping [1,2]. Major depressive disorder (MDD) is a common and serious psychiatric illness. In past study, the authors have done many researches to reveal the change in grey matter [3-7]. However, the neurobiology of MDD is largely unknown. The purpose of the present study was to identify brain regions with gray matter volume and density changes with relative large MDD subjects and controls using optimized voxel-based morphometry. Material and Method Fifty one patients experiencing MDD (mean age = 34.6 ± 12.7, twenty five males and twenty eight females) according to the diagnostic criterion of DSM-IV, who had a score of 18 or greater on the 17-item Hamilton Depression Rating Scale (HAMD), and fifty two age and sex matched normal controls (mean age = 37.2 ± 16.1, twenty three males and twenty eight females) were recruited. MR scanning was carried out on a 3.0 TMR scanner (EXCITE, GE Signa, Milwaukee, USA). High resolution 3-dimensional T1-weighted (T1W) images were acquired employing a spoiled gradient recalled (SPGR) sequence with TR/TE = 8.5/3.4 ms, FA = 120, 156 axial slices with thickness = 1 mm, axial FOV 24 × 24 cm and data matrix = 256 × 256. Optimized voxel-based morphometry [2] was conducted using Statistical Parametric Mapping–2 (SPM2) (Welcome Department of Imaging Neuroscience, London [http://www.fil.ion.ucl.ac.uk/spm]). The voxel-based morphometry–2 toolbox, which implements the optimized voxel-based morphometry approach [2], was used for data preprocessing. Voxel-by-voxel-based comparisons of gray matter density and volume were performed between groups using two-sample t tests. The correlation between the regional gray matter changes and clinical symptom severity was examined. A corrected p value of less than 0.001 was deemed to be significant. Results Patients with MDD exhibited higher grey matter volume than normal controls in multiple brain regions including bilateral thalamus, left and right superior parietal lobule, right frontal lobe (Table 1, Figure 1 A, B and C). MDD patients also showed higher grey matter density than normal controls in bilateral thalamus (cluster level p < 0.001, corrected) (Table 1, Figure 1 D). No significant correlation between regional gray matter changes and HAMD scores was found after controlling for age, years of education and duration of illness.

Association between change in brain gray matter volume, cognition, and depression severity: Pre- and post- antidepressant pharmacotherapy for late-life depression

Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study.

Gray matter volume abnormalities were associated with sustained attention in unmedicated major depression.

Cerebral Volume Measurements and Subcortical White Matter Lesions and Short‐term Treatment Response in Late Life Depression

Brain grey matter volume alterations in late-life depression.

Gray Matter Reorganization Underpinnings of Antidepressant Treatment of Persistent Depressive Disorder.

Brain Grey Matter Volume Alterations Associated with Antidepressant Response in Major Depressive Disorder.

Main and Interactive Effects of Depression and Amnestic Mild Cognitive Impairment on Gray Matter Volumes in Healthy Older Adults: A VBM Study

Influences of resting-state intrinsic functional brain connectivity on the antidepressant treatment response in late-life depression

Relationship between cognition, magnetic resonance white matter hyperintensities, and cardiovascular autonomic changes in late-life depression

Regional Gray Matter Changes Are Associated with Cognitive Deficits in Remitted Geriatric Depression: an Optimized Voxel-Based Morphometry Study

Cognitive Outcomes After Antidepressant Pharmacotherapy for Late-Life Depression: A Systematic Review and Meta-Analysis

Cortical inhibition, facilitation and plasticity in late-life depression: effects of venlafaxine pharmacotherapy

Contribution of neuroimaging in late-life depression

Regional gray matter changes in major depressive disorder : an optimized voxel-based morphometry study

The association between gray matter volume in the hippocampal subfield and antidepressant efficacy mediated by abnormal dynamic functional connectivity

Brain-Cognition Associations in Older Patients With Remitted Major Depressive Disorder or Mild Cognitive Impairment: A Multivariate Analysis of Gray and White Matter Integrity

Longitudinal brain volume changes in major depressive disorder

Longitudinal association between depressive symptoms and cognitive function: the neurological mechanism of psychological and physical disturbances on memory

The Co-Existence of Geriatric Depression and Amnestic Mild Cognitive Impairment Detrimentally Affect Gray Matter Volumes: Voxel-based Morphometry Study

Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squares